Cargando…
Interferon-λ in HCV Infection and Therapy
Chronic infection with hepatitis C virus (HCV) is associated with significant liver disease and is therefore an important public health problem. The current standard-of-care therapy for chronic HCV infection consists of a combination of pegylated (PEG) interferon (IFN)-α and ribavirin. Although this...
Autores principales: | Pagliaccetti, Nicole E., Robek, Michael D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185739/ https://www.ncbi.nlm.nih.gov/pubmed/21994696 http://dx.doi.org/10.3390/v2081589 |
Ejemplares similares
-
Circulating Interferon-λ3, Responsiveness to HBV Vaccination, and HBV/HCV Infections in Haemodialysis Patients
por: Grzegorzewska, Alicja E., et al.
Publicado: (2017) -
Genetic variants in interferon-λ 4 influences HCV clearance in Chinese Han population
por: Huang, Peng, et al.
Publicado: (2017) -
Interferon-λ in the Context of Viral Infections: Production, Response and Therapeutic Implications
por: Hermant, Pascale, et al.
Publicado: (2014) -
Interferon-λ at the Center of the Storm
por: Hendricks, Matthew R., et al.
Publicado: (2020) -
Interferon lambda 4 signals via the IFNλ receptor to regulate antiviral activity against HCV and coronaviruses
por: Hamming, Ole J, et al.
Publicado: (2013)